A study conducted by Pfizer found that GRN-529 reduced repetitive behaviors without sedation and partially increased sociability in mouse models of autism.
Studija sprovedena u kompaniji Pfizer je ustanovila da GRN-529 redukuje repetitivno ponašanje bez sedacije i parcijalno povećava društvenost u mišjim modelima autizma.